The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly. 1985

M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano

GRF (1-40), dopamine (DA), DA plus GRF and placebo were administered to 6 acromegalic patients. The GRF administration induced a highly variable GH release (GH delta % 167.3 +/- 21.4; mean +/- SE). GRF did not provoke any change in PRL serum levels. During simultaneous GRF and DA administration GH release was found to be reduced (GH delta % 80.2 +/- 17.8) compared to that observed for a corresponding period of time after GRF alone (p less than 0.05). Our data underscore that in acromegaly the DA tonus inhibits GH secretion after GRF by acting directly at the pituitary level.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
January 1998, Life sciences,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
April 1987, European journal of pharmacology,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
February 1985, The Journal of clinical endocrinology and metabolism,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
July 1986, The Journal of clinical endocrinology and metabolism,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
January 1985, Endocrinology,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
August 1994, The Journal of clinical endocrinology and metabolism,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
May 1987, General and comparative endocrinology,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
January 1990, Psychoneuroendocrinology,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
April 1993, Journal of developmental physiology,
M Giusti, and A Lomeo, and G Mazzocchi, and D Mignone, and P Sessarego, and M Monachesi, and G Giordano
November 1984, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!